| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871966 | The Annals of Thoracic Surgery | 2015 | 9 Pages |
Abstract
MABG results in significantly enhanced long-term survival compared with LITA/SVG SABG regardless of the degree of LV dysfunction. These results favor MABG as the therapy of choice in patients with LV dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Thomas A. MD, MBA, Laila MS, Robert F. MD, Kamellia R. MD, Darryl M. FRCS, MD, Charles M. MD, Milo C. MD, Mark R. MD, Robert H. PhD,